Cargando…

Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study

INTRODUCTION: Overweight or obese children develop abnormal endothelial cell dysfunction and arterial intima–media thickening with increased vasomotor tone and inflammation. Curcumin, resveratrol, zinc, magnesium, selenium, and vitamin D have shown beneficial effects on endothelial function. We test...

Descripción completa

Detalles Bibliográficos
Autores principales: Pecoraro, Luca, Zoller, Thomas, Atkinson, Richard L., Nisi, Fulvio, Antoniazzi, Franco, Cavarzere, Paolo, Piacentini, Giorgio, Pietrobelli, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748969/
https://www.ncbi.nlm.nih.gov/pubmed/35013093
http://dx.doi.org/10.1038/s41387-021-00180-1
_version_ 1784631128464818176
author Pecoraro, Luca
Zoller, Thomas
Atkinson, Richard L.
Nisi, Fulvio
Antoniazzi, Franco
Cavarzere, Paolo
Piacentini, Giorgio
Pietrobelli, Angelo
author_facet Pecoraro, Luca
Zoller, Thomas
Atkinson, Richard L.
Nisi, Fulvio
Antoniazzi, Franco
Cavarzere, Paolo
Piacentini, Giorgio
Pietrobelli, Angelo
author_sort Pecoraro, Luca
collection PubMed
description INTRODUCTION: Overweight or obese children develop abnormal endothelial cell dysfunction and arterial intima–media thickening with increased vasomotor tone and inflammation. Curcumin, resveratrol, zinc, magnesium, selenium, and vitamin D have shown beneficial effects on endothelial function. We test, among overweight and obese pediatric subjects, the effects on the endothelium of a combination of curcumin, resveratrol, zinc, magnesium, selenium, and vitamin D. METHODS: Forty-eight subjects (6–17 years) were randomized into two groups (placebo vs treatment) attended three visits at 0, 3, and 6 months (±15 days). Endothelial function was assessed by means of a post-occlusive release hyperemic (PORH) test for estimation of delta flow (DF) and hyperemic AUC index, and a heat provocation test (HPT) to measure DF HPT (DF(HPT)). RESULTS: Significant DF difference was noted at 6 months in both groups (p < 0.001). Overall time trend was significantly different between baseline, 3 months, and 6 months both in placebo (p < 0.05) and treatment (p < 0.001) groups and their comparison (p < 0.001). No differences were noted in hyperemic AUC index (3 and 6 months), whilst there were significant differences in time trends of rreatment (p < 0.001) and placebo (p < 0.05) groups and their comparison (p < 0.001). DF(HPT) difference between groups was significant at 3 and 6 months (p < 0.05). The overall time trend was significant exclusively in Treatment group between 3 and 6 months (p < 0.05). Correlation with anthropometrics was found for DF and body mass index (r = 0.677 6 months, p < 0.05), as well as for hyperemic AUC index and males (r = 0.348, p < 0.05), while DF(HPT) showed no correlation. CONCLUSION: Curcumin, resveratrol, zinc, magnesium, selenium, and vitamin D appear to be promising in enhancing endothelial function by improvement of both DF in the PORH test and DF in the HPT, lowering the risk of developing cardiovascular diseases in overweight and obese pediatric subjects.
format Online
Article
Text
id pubmed-8748969
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87489692022-01-20 Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study Pecoraro, Luca Zoller, Thomas Atkinson, Richard L. Nisi, Fulvio Antoniazzi, Franco Cavarzere, Paolo Piacentini, Giorgio Pietrobelli, Angelo Nutr Diabetes Article INTRODUCTION: Overweight or obese children develop abnormal endothelial cell dysfunction and arterial intima–media thickening with increased vasomotor tone and inflammation. Curcumin, resveratrol, zinc, magnesium, selenium, and vitamin D have shown beneficial effects on endothelial function. We test, among overweight and obese pediatric subjects, the effects on the endothelium of a combination of curcumin, resveratrol, zinc, magnesium, selenium, and vitamin D. METHODS: Forty-eight subjects (6–17 years) were randomized into two groups (placebo vs treatment) attended three visits at 0, 3, and 6 months (±15 days). Endothelial function was assessed by means of a post-occlusive release hyperemic (PORH) test for estimation of delta flow (DF) and hyperemic AUC index, and a heat provocation test (HPT) to measure DF HPT (DF(HPT)). RESULTS: Significant DF difference was noted at 6 months in both groups (p < 0.001). Overall time trend was significantly different between baseline, 3 months, and 6 months both in placebo (p < 0.05) and treatment (p < 0.001) groups and their comparison (p < 0.001). No differences were noted in hyperemic AUC index (3 and 6 months), whilst there were significant differences in time trends of rreatment (p < 0.001) and placebo (p < 0.05) groups and their comparison (p < 0.001). DF(HPT) difference between groups was significant at 3 and 6 months (p < 0.05). The overall time trend was significant exclusively in Treatment group between 3 and 6 months (p < 0.05). Correlation with anthropometrics was found for DF and body mass index (r = 0.677 6 months, p < 0.05), as well as for hyperemic AUC index and males (r = 0.348, p < 0.05), while DF(HPT) showed no correlation. CONCLUSION: Curcumin, resveratrol, zinc, magnesium, selenium, and vitamin D appear to be promising in enhancing endothelial function by improvement of both DF in the PORH test and DF in the HPT, lowering the risk of developing cardiovascular diseases in overweight and obese pediatric subjects. Nature Publishing Group UK 2022-01-10 /pmc/articles/PMC8748969/ /pubmed/35013093 http://dx.doi.org/10.1038/s41387-021-00180-1 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Pecoraro, Luca
Zoller, Thomas
Atkinson, Richard L.
Nisi, Fulvio
Antoniazzi, Franco
Cavarzere, Paolo
Piacentini, Giorgio
Pietrobelli, Angelo
Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study
title Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study
title_full Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study
title_fullStr Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study
title_full_unstemmed Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study
title_short Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study
title_sort supportive treatment of vascular dysfunction in pediatric subjects with obesity: the obelix study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748969/
https://www.ncbi.nlm.nih.gov/pubmed/35013093
http://dx.doi.org/10.1038/s41387-021-00180-1
work_keys_str_mv AT pecoraroluca supportivetreatmentofvasculardysfunctioninpediatricsubjectswithobesitytheobelixstudy
AT zollerthomas supportivetreatmentofvasculardysfunctioninpediatricsubjectswithobesitytheobelixstudy
AT atkinsonrichardl supportivetreatmentofvasculardysfunctioninpediatricsubjectswithobesitytheobelixstudy
AT nisifulvio supportivetreatmentofvasculardysfunctioninpediatricsubjectswithobesitytheobelixstudy
AT antoniazzifranco supportivetreatmentofvasculardysfunctioninpediatricsubjectswithobesitytheobelixstudy
AT cavarzerepaolo supportivetreatmentofvasculardysfunctioninpediatricsubjectswithobesitytheobelixstudy
AT piacentinigiorgio supportivetreatmentofvasculardysfunctioninpediatricsubjectswithobesitytheobelixstudy
AT pietrobelliangelo supportivetreatmentofvasculardysfunctioninpediatricsubjectswithobesitytheobelixstudy